Biotinylated Human FOLR1 Protein (C-His-Avi)

Product Details


ApplicationELISA, BLI
FormatLiquid, Biotinylated
Expression HostCHO
Target NameFOLR-1, FBP, FOLR, FRα
SpeciesHuman
SourcesHuman FOLR1 (Arg25-Met233) with C-terminus His-Avi Tag is expressed in CHO cells. This protein was site-specifically labeled with Biotin by BirA ligase.
accession numberP15328
Molecular WeightThe protein has a predicted molecular weight of 28.6kDa. Under DTT-reducing conditions, it migrates at approximately 35-45 kDa on SDS-PAGE.
Affinity TagC-His-Avi
Purity>95% based on SDS-PAGE under reducing condition
Formulation1xPBS buffer, pH7.4, 0.22 µm filtered
Endotoxin levelNot tested
Protein Concentration25µg size is bottled at 0.2mg/mL concentration. 100 µg size is supplied at a lot-specific concentration.
Storage and HandlingBriefly centrifuge the vial upon receipt. An unopened vial can be stored at 4°C for up to 2 weeks, or at -20°C or below for up to six months. The protein may be further diluted to 0.1 mg/mL using 0.22 µm-filtered PBS buffer (pH 7.4). For long-term storage, the diluted stock solution should be aliquoted and stored at ≤ –70°C to minimize freeze-thaw cycles. If additional dilution is required, carrier proteins such as FBS or BSA should be added to maintain protein stability.

Background Information


The FOLR1 gene encodes a protein that is a member of the folate receptor family, responsible for binding folic acid and its reduced derivatives, and transporting 5-methyltetrahydrofolate into cells. The protein is typically anchored to cell membranes via a glycosyl-phosphatidylinositol (GPI) linkage or exists in a soluble form. Mutations in FOLR1 are associated with neurodegeneration due to cerebral folate transport deficiency. This gene has multiple transcript variants due to alternative splicing and the presence of two promoters and various transcription start sites. Folate receptor α (FRα), the key subunit of the folate receptor, is primarily expressed in epithelial cells and is selectively overexpressed in cancer types like breast and ovarian cancers. While normal cells rely on the reduced folate carrier for folate uptake, many carcinomas and myeloid leukemia cells overexpress FRα to support rapid cell division, reflecting their higher need for folate.